Particle size of oyster shell meal and calcium: phosphorus ratios in broiler diets / Efeito do tamanho de partícula da farinha de ostras e relações cálcio: fósforo em dietas para frangos de corte

The effects of Ca:P total ratio and particle size of oyster shell meal (OSM) were evaluated in broiler diets. In Experiment 1, 800 broilers (22-42 days old) were distributed in a 2×2 factorial design, with two Ca:P ratios (1.7 and 2.0:1) and two OSM particle sizes (coarse = 1,354 µm and fine = 428 µm), totaling four treatments with 10 repetitions with 20 broilers. Feed intake, weight gain, and feed conversion ratio were calculated. In Experiment 2, 1,280 broilers were distributed in a 2×2×2 factorial design (1.7 and 2.0:1 Ca:P ratios; coarse and fine OSM; male and female broilers), with eight treatments and 16 repetitions with 10 broilers. Apparent metabolizability of dry matter, Ca, P, and apparent metabolizable energy (AME), as well as bone resistance, bone weight, ash, Ca, and P content in the tibia were assessed. Growth performance was not affected (P > 0.05). Coarse OSM increased tibia Ca content in male broilers (P < 0.001), and higher Ca:P ratio improved bone ash and bone resistance in both sexes (P < 0.001), but reduced P content in male broilers (P < 0.05); male broilers displayed heavier bones with higher ash content than females (P < 0.05). Metabolizability of Ca was improved with coarse OSM (P < 0.05); whereas metabolizability of DM, P, and AME was not affected (P > 0.05). In conclusion, diets with a Ca:P total ratio of 2.0:1 containing coarser OSM improved bone mineral composition, particularly in male broilers, and coarse OSM improved the metabolizability of Ca in broilers regardless of the Ca:P total ratio or broiler sex.

Dois experimentos foram conduzidos para avaliar os efeitos do tamanho de partícula da farinha de ostras (FO) e relação Ca:P total em dietas para frangos de corte. No primeiro experimento, 800 frangos (22 a 42 dias) foram distribuídos em um delineamento fatorial 2x2: 2 relações Ca:P (1,7 e 2,0:1) e dois tamanhos de partícula da FO (grossa = 1354 µm e fina = 428 µm), totalizando quatro tratamentos com 10 repetições de 20 aves. O consumo de ração, o ganho de peso e a conversão alimentar foram calculados. No segundo experimento, 1.280 frangos foram distribuídos em um fatorial 2x2x2 (relações Ca:P 1,7 e 2,0:1; FO grossa e fina; aves machos e fêmeas) com oito tratamentos e 16 repetições de 10 aves. Foram avaliados: metabolizabilidade aparente da matéria seca, Ca e P, energia metabolizável aparente (EMA), peso e resistência óssea, conteúdo de cinzas, Ca e P na tíbia. As variáveis de desempenho não foram afetadas (P > 0,05). O uso de FO grossa aumentou o conteúdo de Ca na tíbia de frangos machos (P < 0,001), e a relação Ca:P de 2,0:1 aumentou o conteúdo de cinzas e aprimorou resistência óssea em ambos os sexos (P < 0,001), porém reduziu P na tíbia dos machos (P < 0,05); frangos machos também tiveram ossos mais pesados e maior conteúdo de cinzas do que fêmeas (P < 0,05). A metabolizabilidade de Ca foi melhorada com FO grossa, enquanto a metabolizabilidade da matéria seca, P, e EMA não foram afetadas (P > 0,05). Conclui-se que as dietas com relação Ca:P de 2,0:1 e com FO grossa resultaram em melhor composição mineral óssea - particularmente em frangos machos - e a FO grossa melhorou a metabolizabilidade de Ca independentemente da relação Ca:P ou do gênero das aves.

The pivotal role of autophagy in bone cells:bone-related cell activity and bone metabolism / 中国组织工程研究

BACKGROUND:The importance of autophagy for maintaining cellular homeostasis and stress response has long been recognized.As a way for cells to selectively clear their damaged organelles to achieve the recycling of cellular components,autophagy has a pivotal role in bone metabolism.OBJECTIVE:To review the role and possible mechanisms of autophagy in regulating bone-related cell activity and function among bone marrow mesenchymal stem cells,osteoblasts,osteocytes,and osteoclasts.METHODS:PubMed was searched for studies related to autophagy using the keywords of "autophagy;bone marrow mesenchymal stem cells;osteoblasts;osteocytes;osteoclasts."RESULTS AND CONCLUSION:We finally included 84 papers.Autophagy plays an important role in bone metabolism.Autophagy is involved in maintaining the balance between mineralization and absorption,and then maintaining bone homeostasis.An appropriate autophagy inducer may also benefit bone remodeling.Abnormal autophagy can lead to disorders of bone balance,leading to diseases such as osteoporosis.We may prevent or treat bone-related diseases by regulating the level of autophagy as its function in maintaining the balance of mineralization and resorption in bone homeostasis.

Histomorphometry evaluation of bone anabolism promoted by prostaglandin E1 and its relation to hypercalcemia / Evaluación histomorfométrica del anabolismo óseo en la reparación promovida por la prostaglandina E1 y su relación con la hipercalcemia

Abstract Background: At present, parathyroid hormone is the only existing anabolic bone therapy but produces hypercalcemia. Prostaglandin E1 (PGE1) has been suggested as a bone anabolic agent that allows bone modeling formation without producing hypercalcemia. This study aimed to corroborate these PGE1 properties. Methods: For 22 days, rabbits (n = 30) were divided into three groups (n = 10 each group) and received intravenous solutions: vehicle (control group), palate disjunction + vehicle (sham group), and palate disjunction + 50 mg of PGE1 (PGE1 group). On days 1, 3, and 22, palatine suture X-rays were taken. On day 22, bone formation markers were analyzed, and the rabbits were sacrificed. Bone palate undecalcified samples were processed. Histomorphometry software was used to analyze bone parameters, and the mineralization front was stained with toluidine blue. Scalloped lines reflect remodeling-based bone formation (RBF), and smooth lines reflect modeling-based formation (MBF). Results: X-rays showed more significant palatal disjunction in the PGE1 group; this group exhibited significant calcitriol serum increments. Hypercalciuria was observed in the PGE1 group, and resorption markers (N-telopeptides) remained stable. Sutural bones in the PGE1 group exhibited significant anabolism in structural parameters. RBF was 20%, and MBF was 6% in the sham group; in the PGE1 group, RBF was 8.6%, and MBF was 17%. In the PGE1 group, mineralization was significantly accelerated, but resorption remained stable. Conclusions: This model suggests that PGE1 favors palate disjunction, calcitriol synthesis, and shortens the mineralization. Therefore, PGE1 is an important bone anabolic molecule predominantly of modeling-based form and no hypercalcemia.

Resumen Introducción: La hormona paratiroidea es la única molécula anabólica ósea, pero ocasiona hipercalcemia. La prostaglandina E1 (PGE1) sugiere ser un anabólico óseo con formación por modelación predominante y generalmente no ocasiona hipercalcemia. El objetivo de este estudio fue corroborar estas propiedades de la PGE1. Métodos: Por 22 días, 30 conejos divididos en tres grupos (n = 10 cada grupo) recibieron una solución por vía intravenosa: vehículo (grupo control), disyunción palatina más vehículo (grupo sham) y disyunción palatina más 50 mg de PGE1 (grupo PGE1). A los días 1, 3 y 22 se obtuvieron radiografías de la sutura palatina. En el día 22 se analizaron los marcadores bioquímicos de formación ósea y se sacrificó a los conejos. Las suturas y los huesos suturales se procesaron sin descalcificar. La evaluación histomorfométrica fue digitalizada y el frente de mineralización ósea se tiñó con azul de toluidina. Las líneas irregulares reflejan resorción (remodelación) y las líneas rectas no resorción (modelación). Resultados: Radiográficamente, la disyunción palatina fue mayor en el grupo PGE1. Este grupo mostró una hipercalcitonemia significativa, pero la calcemia y los marcadores resortivos (N-telopéptidos) se mantuvieron estables. Por histomorfometría, los huesos suturales del grupo PGE1 mostraron anabolismo significativo en parámetros estructurales. En el grupo sham, la remodelación ósea fue del 20% y la modelación fue del 6%; en el grupo PGE1, la remodelación fue del 8.6% y la modelación fue del 17%. En este mismo grupo, la mineralización fue significativamente acelerada, pero la resorción se mantuvo igual. Conclusiones: Este modelo sugiere que la PGE1 favorece la disyunción palatina y el aumento del calcitriol, y acelera la mineralización y el anabolismo óseo por modelación predominante sin hipercalcemia.

Expert consensus on clinical management of metabolic bone disease of prematurity (2021) / 中国当代儿科杂志

Metabolic bone disease of prematurity (MBDP) is a systemic bone disease with a reduction in bone mineral content due to disorder of calcium and phosphorus metabolism. There is still a lack of in-depth research and systematic understanding of MBDP in China, and there are many irregularities in clinical management of this disease. Based on relevant studies in China and overseas, Grading of Recommendations Assessment, Development and Evaluation was used to develop the expert consensus on the clinical management of MBDP, which provides recommendations from the following five aspects: high-risk factors, screening/diagnosis, prevention, treatment, and post-discharge follow-up of MBDP, so as to provide relevant practitioners with recommendations on the clinical management of MBDP to reduce the incidence rate of MBDP and improve its short- and long-term prognosis.

Sp7/osterix positively regulates dlx2b and bglap to affect tooth development and bone mineralization in zebrafish larvae

Osterix (or Sp7) is an important transcription factor that promotes osteoblast differentiation by modulating the expression ofa range of target genes. Although many studies have focused on Osterix/Sp7 regulatory mechanisms, the detailed functionshave not been fully elucidated. Toward this end, in this study, we used CRISPR/Cas9 technology to knock out the zebrafishsp7 gene, and then analyzed its phenotype and biological function. Two knockout sp7 mutant lines were successfullyobtained. The bone mineralization level was significantly reduced in the zebrafish sp7-/- homozygote, resulting inabnormal tooth development in the larvae. Quantitative real-time polymerase chain reaction showed that loss of sp7 led todown-regulated expression of the dlx2b and bglap genes related to tooth development and bone mineralization, respectively. Moreover, cell transfection experiments demonstrated that Sp7 directly regulates the expression of dlx2b and bglapthrough Sp7-binding sites on the promoter regions of these two genes. Overall, this study provides new insight into the roleof Sp7 in bone mineralization and tooth development.

Experimental study of periostin promoting rapid distraction osteogenesis of the rabbit mandible / 口腔疾病防治

Objective @#To explore the promoting effect of periostin on rapid distraction osteogenesis of the rabbit mandible and provide experimental evidence for the clinical use of periostin to promote osteogenesis.@*Methods@#Twenty-four New Zealand male white rabbits underwent distraction osteogenesis, and after 3 days of retention, they were rapidly stretched at a stretch rate of 2 mm/d (total 5 d). The animals were randomly divided into group A and group B (12 per group). On the last day of the stretch, 0.5 mL of normal saline containing 40 μg of recombinant periostin was given to group B or an equal volume of normal saline was added to the control group (group A) for 8 days. At 4 weeks and 8 weeks post-stretch, 8 animals were randomly selected from each group to undergo a CT scan under general anesthesia. The bone mineral density and bone mineral content were detected by dual energy X-ray absorptiometry. Eight weeks post-stretch, all of the experimental animals were sacrificed. Six animals were randomly selected from each group for micro-CT and a histological examination, and the remaining animals were subjected to biomechanical tests. @*Results @#CT images showed that the new bone formation in the distraction space of group B was significantly better than that of group A at 4 and 8 weeks post-stretch. At 4 weeks and 8 weeks post-stretch, the bone mineral density in group B was (0.157 ± 0.016) g/cm 2 and (0.234 ± 0.023) g/cm 2, respectively, and the bone mineral content was (0.096 ± 0.010) g and (0.204 ± 0.017) g, respectively. The above four means were significantly higher in group B than in group A (P < 0.001). The micro-CT images and data suggest that the stretch gap microstructure of group B has more mature features. Histological experiments showed that the trabecular bone of group B was thick and mature, with few chondrocytes. The biomechanical test results showed that the biomechanical strength of the distraction gap in group B was (228.47 ± 39.98) N, which was 1.24 times that of group A (P = 0.045).@*Conclusion@# Interstitial use of periosteal protein in the distraction space of the mandible in rabbits can promote local new bone formation and mineralization.

Cellular zinc deficiency inhibits the mineralized nodule formation and downregulates bone-specific gene expression in osteoblastic MC3T3-E1 cells / 한국영양학회지

PURPOSE: Zinc (Zn) is an essential trace element for bone mineralization and osteoblast function. We examined the effects of Zn deficiency on osteoblast differentiation and mineralization in MC3T3-E1 cells. METHODS: Osteoblastic MC3T3-E1 cells were cultured at concentration of 1 to 15 µM ZnCl2 (Zn− or Zn+) for 5, 15 and 25 days up to the calcification period. Extracellular matrix mineralization was detected by staining Ca and P deposits using Alizarin Red and von Kossa stain respectively, and alkaline phosphatase (ALP) activity was detected by ALP staining and colorimetric method. RESULTS: Extracellular matrix mineralization was decreased in Zn deficiency over 5, 15, and 25 days. Similarly, staining of ALP activity as the sign of an osteoblast differentiation, was also decreased by Zn deficiency over the same period. Interestingly, the gene expression of bone-related markers (ALP, PTHR; parathyroid hormone receptor, OPN; osteopontin, OC; osteocalcin and COLI; collagen type I), and bone-specific transcription factor Runx2 were downregulated by Zn deficiency for 5 or 15 days, however, this was restored at 25 days. CONCLUSION: Our data suggests that Zn deficiency inhibits osteoblast differentiation by retarding bone marker gene expression and also inhibits bone mineralization by decreasing Ca/P deposition as well as ALP activity.

Research progress on drugs in osteoporosis therapy / 药学实践杂志

Osteoporosis (OP) is a systemic bone metabolism disease characterized by a systemic impairment of bone mass ,strength ,and microarchitecture ,which will be result in increasing the propensity of fragility fractures .In recent years , OP becomes a worldwide health problem and a hotspot in medical research due to its increasing incidence .Anti-resorptive drugs inhibit osteoclast differentiation and maturation in order to reduce bone resorption ;Bone-anabolic drugs promote the bone for-mation function of osteoblast and reconstruct bone tissue ;Bone mineralization-acceleration drugs are the basic material for pre-vention and treatment of osteoporosis ,including calcium and vitamin D ;Strontium ranelate is the representative drug of un-coupling agents .In this paper ,the current progress of osteoporosis treatments were reviewed including these proposed drugs .

Bone characteristics of pigs fed different sources of phosphorus / Características óseas de cerdos alimentados con diferentes fuentes de fósforo / Características ósseas de suínos alimentados com diferentes fontes de fósforo

Summary Background: phosphorus supplementation should help to keep bone integrity and prevent fractures during the development and slaughter of animals. Objective: to evaluate the effect of different phosphorus sources on one characteristics of pigs. Methods: one-hundred and twelve piglets (28.65 ± 2.82 Kg body weight) were distributed into an 8×2 factorial arrangement (eight sources of phosphorus × two sexes) in blocks in a completely randomized design. The diets were formulated on a total-phosphorus basis, with 0.32 and 0.31% of P for the control diet and 0.56 and 0.42% of P for the other treatments in the growth and finishing phases, respectively. Phosphorus was supplemented as dicalcium phosphate (DCP); mono-dicalcium phosphate (MDCP); triple superphosphate (TSP); single superphosphate (SSP); Catalão-rock phosphate (ROCK); a mixture of sources (MIX); phosphoric acid (PPA); and the control diet (CTR). Results: there was no interaction between phosphorus sources and sex in any of the parameters. Thickness of the compact tissue was the lowest in the CTR, differing from the diets containing DCP, MDCP, and PPA, followed by diets SSP, TSP, and ROCK, with the greatest value for MDCP. Porosity of the compact tissue was higher for the CTR and SSP diets. Conclusion: the use of less elaborate sources of phosphorus, such as rock phosphate and single superphosphate, was less effective than the other sources to improve bone integrity of pigs.

Resumen Antecedentes: la suplementación dietaria con fósforo ayuda a mantener la integridad del hueso y prevenir fracturas durante el desarrollo y sacrificio de los animales. Objetivo: evaluar el efecto de diferentes fuentes de fósforo sobre las características óseas de los cerdos. Métodos: ciento doce lechones (peso corporal: 28,65 ± 2,82 Kg) se distribuyeron en un arreglo factorial 8×2 (ocho fuentes de fósforo × dos sexos) en bloques al azar. Las dietas se formularon con base en fósforo total, con 0,32 y 0,31% de P para la dieta control y 0,56 y 0,42% de P para los otros tratamientos en las fases de crecimiento y finalización, respectivamente. El fósforo se suplementó como fosfato dicálcico (DCP), monofosfato dicálcico (MDCP), superfosfato triple (TSP), superfosfato simple (SSP), fosfato de roca Catalão (ROCK), mezcla de fuentes (MIX), ácido fosfórico (PPA) y dieta control (CTR). Resultados: no se observó interacción entre las fuentes de fósforo y el sexo en ninguno de los parámetros estudiados. El espesor del tejido compacto fue más bajo en el CTR, y diferente a las dietas que contenían DCP, MDCP y PPA, seguido por las dietas SSP, TSP y ROCK; con el mayor valor para MDCP. La porosidad del tejido compacto fue mayor para las dietas CTR y SSP. Conclusión: el uso de fuentes menos elaboradas de fósforo, tales como el fosfato de roca y superfosfato simple, fue menos efectivo que las otras fuentes en mejorar la integridad ósea de los cerdos.

Resumo Antecedentes: a suplementação de fósforo deve manter a integridade do tecido ósseo e prevenir fraturas durante o desenvolvimento e abate dos animais. Objetivo: avaliar o efeito de diferentes fontes de fósforo sobre as características ósseas dos suínos. Métodos: cento e doze leitões com peso médio inicial de 28,65 ± 2,82 Kg foram distribuídos em esquema fatorial 8×2 (oito fontes de fósforo × dois sexos) em blocos casualizados. As dietas foram formuladas baseadas em fósforo total com 0,32 e 0,31% de P para a dieta controle e com 0,56 e 0,42% de P para os outros tratamentos nas fases de crescimento e terminação, respectivamente. O fósforo nas dietas foi suplementado com fosfato bicálcico (DCP); mono-fosfato bicálcico (MDCP); superfosfato triplo (TSP); superfosfato simples (SSP); fosfato de rocha Catalão (ROCK); uma mistura de fontes (MIX); ácido fosfórico (PPA); e a dieta controle (CTR). Resultados: não houve interação entre as fontes de fósforo e sexo dos animais para qualquer um dos parâmetros estudados. A espessura do tecido compacto é menor na CTR, diferenciando-se das dietas DCP, MDCP e PPA, seguido pelas dietas SSP, TSP e ROCK, sendo que o maior valor foi observado na dieta com MDCP. A porosidade do tecido compacto foi maior com as dietas CTR e SSP. Conclusão: o uso de fontes menos elaboradas de fósforo como superfosfato simples e fosfato de rocha foram menos eficientes do que os outros tratamentos para melhorar a integridade óssea de suínos.

Evaluation of using two metabolites of Vitamin D3 with phytase in the diet of laying hens finishing their productive cycle / Evaluación del empleo de dos metabolitos de vitamina D3 con fitasa en la dieta de gallinas ponedoras finalizando el ciclo productivo / Avaliação da utilização de dois metabolitos da vitamina D3 com fitasse na dieta de galinhas poedeiras finalizando o ciclo produtivo

The effect of supplementing the diet with two sources of vitamin D3, 1α-hidroxycholecalciferol (1α-OH-D3) and 25-hidroxycholecalciferol (25-OH-D3), in the presence of phytase, on the productive indicators, the bone mineral composition and the external quality of the eggs of comercial laying hens during weeks 55 to 68 of life. A total of 360 Lohman Brown hens were used, distributed between four treatments with six replicates per treatment and 15 birds per replicate. The diets were: T1 (diet with 50g ton-1 of phytose), T2 (same as T1 plus 12.5g ton-1 of 1α-OH-D3 without considering the phosphorus and calcium contributions), T3 (same as T1 with the addition of 12. 5g ton-1 considering a liberation of 0.05% of available phosphorus and calcium ), and T4 (same as T1 with the addition of 5.52g ton-1 of 25-OH-D3 considering a liberation of 0.05% of available phosphorus and calcium). All birds had free Access to wáter and food according to recomendations for comercial lines. The variables laying percentage, cumulative conversión, egg quality, Shell minerals, percentage of Shell in the egg, egg density, and bone minerals were not significantly influenced (p>0.05) by the source or type of inclusión of vitamin D3. However, the use of vitamin 1α-OH-D3 in a matrix showed a net economic benefit, representing the lowest production cost and highest income for egg sales. In future research with laying hens, it is necessary to check the level of inclusión of vitamin D3 as well as the concentration of calcium in the diet.

Se evaluó el efecto de la suplementación de dos fuentes de vitamina D3 , 1α-hidroxicolecalciferol (1α-OH-D3,) y 25-hidroxicolecalciferol (25-OH-D3 ), en la presencia de fitasa, sobre los indicadores productivos, la composición mineral ósea y la calidad externa del huevo de gallinas de postura comercial durante las semanas 55 a la 68 de vida Se utilizaron 360 gallinas Lohmann Brown, distribuidas entre cuatro tratamientos con seis réplicas por tratamiento y quince aves por replica. Las dietas fueron: T1 (dieta con 50 g ton-1 de fitasa), T2 (igual a T1 más la adición de 12,5 g ton-1 de 1α-OH-D3 sin valorar los aportes de calcio y fósforo), T3 (igual a T1 con la adición de 12,5 g ton-1 de 1α-OH-D3 considerando una liberación de 0,05% del fósforo y calcio disponible), T4 (igual a T1 con la adición de 5,52 g ton-1 de 25-OH-D3 considerando una liberación de 0,05% del fósforo y calcio disponible). Todas las aves tuvieron acceso a agua y alimento de acuerdo a la recomendación para la línea comercial. Las variables porcentaje de postura, conversión acumulada, calidad de huevo, minerales en cáscara, % de cáscara en huevo, densidad de huevos y minerales en huesos no fueron influenciadas significativamente (p>0,05) por la fuente ni el tipo de inclusión de la vitamina D3 . Sin embargo, el uso de la vitamina 1α-OH-D3 matrizada mostró un beneficio económico neto, representado en menor costo de producción y mayor ingreso por ventas de huevo. En futuras investigaciones con ponedoras, es necesario verificar tanto el nivel de inclusión de vitamina D3 como la concentración de calcio de la dieta..

Avaliou-se o efeito da suplementação de dois fontes de vitamina D3 , 1α-hidroxicolecalciferol (1α-OH-D3,) e 25-hidroxicolecalciferol (25-OH-D3 ), na presença de fitasse sobre os indicadores produtivos, a composição mineral óssea e a qualidade externa do ovo de galinhas poedeiras comerciais entre as semanas 55 e 68. Utilizaram-se 362 galinhas Lohman Brown, distribuídas em quatro tratamentos com seis réplicas por tratamento e 15 aves por replica. As dietas foram: T1 (dieta com 50 g ton-1 de fitasse), T2 (igual a T1 mais a adição de 12,5 g ton-1 de 1α-OH-D3 sem valorar os aportes de cálcio e fósforo), T3 (igual a T1 com a adição de 12,5 g ton-1 de 1α-OH-D3 considerando uma liberação de 0,05% de fósforo e cálcio disponível), T4 (igual a T1 com a adição de 5,52 g ton-1 de 25-OH-D3 considerando uma liberação de 0,05% do fósforo e cálcio disponível). Todas as aves tiveram aceso a agua e alimento de acordo a recomendação para linha comercial. As variáveis: porcentagem de postura, conversão acumulada, qualidade do ovo, minerais em casca, % de casca em ovo, densidade do ovo e minerais em ossos não foram influenciadas significativamente (p>0,05) pela fonte nem pelo tipo de inclusão de vitamina D3 . Embora, a utilização da vitamina 1α-OH-D3 matrizada mostrou um benefício económico neto, representado pelo menor custo de produção e maior ingresso por ventas de ovos. Em futuras pesquisas com poedeiras, é necessário verificar tanto o nível de inclusão de vitamina D3 quanto a concentração de cálcio na dieta..

Avaliação funcional de implantes por mineralização óssea in vitro / Functional evaluation of implants by bone mineralization in vitrot

A evolução do projeto dos implantes osseointegráveis é resultado do desenvolvimento de diferentes tipos de estruturas em sua superfície. No entanto, ainda existe a necessidade de estudos para definir o tipo de superfície ideal. Esse trabalho discute métodos de avaliação da superfície de implantes que mostram o potencial de determinadas superfícies para induzir mineralização óssea in vitro, partir do uso de células mesenquimais progenitoras. Foram realizadas análises comparativas entre a topografia de implantes com e sem rugosidades nanométricas e o tipo de interação entre pré-osteoblastos semeados diretamente nesses implantes. Características distintas foram observadas em cada superfície.

Improvements in dental implants structure is the result of development of different types of geometrically intelligent surfaces, provided by the emergence of companies interested in innovation of these materials, however, there is still a need for studies to define the type of ideal surface. This work addresses an unprecedented discussion regarding implant surface evaluation methods, able to show the potential of certain areas to induce bone mineralization in vitro. From the use of mesenchymal progenitor cells, which have the capacity to respond to stimuli surface, comparative tests were performed between the topography implants with and without nano-roughness and the type of functional interaction between pre-osteoblasts seeded directly into these implants. Different characteristics of coating cells and mineralization niches on different surfaces were found.

Relationship between chronological and bone ages and pubertal stage of breasts with bone biomarkers and bone mineral density in adolescents / Relação entre as idades cronológica e óssea e o estágio puberal das mamas com os biomarcadores ósseos e a densidade mineral óssea em adolescentes

OBJECTIVE: To study bone mineral density (BMD) in adolescent females according to five groups of chronological age (CA), bone age (BA), and breast development stage (B), and to correlate these parameters with plasma bone biomarkers (BB). METHODS: This was a cross-sectional study performed in 101 healthy adolescent females between 10 and 20 years old. The study variables were: weight, height, body mass index (BMI), CA, B, BA, calcium intake, BMD, and BB. Osteocalcin (OC), bone alkaline phosphatase (BAP), and C-terminal telopeptide (S-CTx) were evaluated for BB. BMD was measured using dual energy X-ray absorptiometry (DXA). RESULTS: BMD in lumbar spine, proximal femur, and total body increased with age, and the respective observed averages were: in CA1 (10 years old), 0.631, 0.692, 0.798 g/cm2; in CA2 (11 to 12 years old), 0.698, 0.763, 0.840 g/cm2; in CA3 (13 to 14 years old), 0.865, 0.889, 0.972 g/cm2; in CA4 (15 to 16 years old), 0.902, 0.922, 1.013 g/cm2; and in CA5 (17 to 19 years old), 0.944, 0.929, 1.35 g/cm2. These results showed significant differences between 13 and 14 years of age (CA3) or when girls reached the B3 stage (0.709, 0.832, 0.867 g/cm2). The highest median concentrations of BB were between 10 and 12 years of age when adolescents were in the B2-B3 (p < 0.001). Median BB concentrations decreased in advanced BA and B. CONCLUSIONS: BB concentrations were positively correlated with the peak height velocity and negatively correlated with BMD in the study sites. Increased BMD and BB concentrations were observed in B3. .

OBJETIVO: Avaliar a densidade mineral óssea (DMO) em adolescentes do sexo feminino de acordo com a idade cronológica (IC), idade óssea (IO) e desenvolvimento das mamas (M) e suas correlações com biomarcadores de remodelação óssea em plasma (BO). MÉTODOS: Este foi um estudo transversal prospectivo feito em 101 adolescentes saudáveis do sexo feminino com idade entre 10 e 20 anos. As variáveis estudadas foram: peso, altura, índice de massa corpórea (IMC), IC, IO, M, ingestão de cálcio, DMO e BO. A osteocalcina (OC), fosfatase alcalina óssea (BAP) e o telopeptídeo C terminal (S-CTx) foram os biomarcadores de remodelação óssea avaliados. A DMO foi obtida por absorciometria de raios-X de dupla energia (DXA). RESULTADOS: A DMO de coluna lombar, fêmur proximal e corpo total aumentou com a idade, e as respectivas médias observadas foram: IC1 = 0,631, 0.692, 0,798 g/cm2; IC2, 0,698, 0,763, 0,840 g/cm2; IC3, 0,865, 0,889, 0,972 g/cm2; IC4, 0,902, 0,922, 1,013 g/cm2; e IC5, 0,944, 0,929, 1,35 g/cm2. Observou-se diferença significativa entre 13 e 14 anos (IC3) ou quando as meninas estavam em M3 (0,709, 0,832, 0,867 g/cm2). Os valores dos BO apresentaram elevação entre 10 e 12 anos e quando as adolescentes estavam em M2-M3 (p < 0,001). Os valores das medianas dos BO diminuíram com o avançar da IO e M. CONCLUSÕES: Os BOs mostraram paralelismo com o pico de velocidade de crescimento e demonstraram correlação negativa com a DMO no sítios avaliados. O aumento da DMO e dos BOs foi observado em M3. .

Bone densitometry by dual-energy X-ray absorptiometry (DXA) in preterm newborns compared with full-term peers in the first six months of life / Densitometria óssea de dupla absorção de raio-X (DXA) em crianças nascidas pré-termo comparada com seus pares a termo nos primeiros 6 meses

OBJECTIVES: To longitudinally assess bone mineral content (BMC), bone mineral density (BMD), and whole-body lean mass obtained through bone densitometry by dual-energy X-ray absorptiometry (DXA) in preterm newborns (PTNs) and compare them with full-term newborns (FTNs) from birth to 6 months of corrected postnatal age. METHODS: A total of 28 adequate for gestational age (AGA) newborns were studied: 14 preterm and 14 full-term newborns. DXA was used to determine BMC, BMD, and lean mass in three moments: 40 weeks corrected post-conceptual age, as well as 3 and 6 months of corrected postnatal age. PTNs had gestational age ≤ 32 weeks at birth and were fed their mother's own milk or milk from the human milk bank. RESULTS: All infants had an increase in BMC, BMD, and lean body mass values during the study. PTNs had lower BMC, BMD, and lean mass at 40 weeks of corrected post-conceptual age in relation to FTNs (p < 0.001, p < 0.001, p = 0.047, respectively). However, there was an acceleration in the mineralization process of PTNs, which was sufficient to achieve the normal values of FTNs at 6 months of corrected age. CONCLUSIONS: This study suggests that bone densitometry by dual-energy X-ray absorptiometry is a good method for the assessment of body composition parameters at baseline, and at the follow-up of these PTNs. .

OBJETIVOS: Avaliar longitudinalmente o conteúdo mineral ósseo (CMO), a densidade mineral óssea (DMO) e a massa magra do corpo inteiro obtidos através da densitometria óssea de dupla absorção de Raios-X (DXA) em recém-nascidos pré-termo (RNPT) e comparar com seus pares a termo (RNT) desde o nascimento até 6 meses de idade pós-natal corrigida. MÉTODOS: Foram estudados 28 recém-nascidos adequados para a idade gestacional: 14 recém-nascidos pré-termo e 14 recém-nascidos a termo. Utilizando-se a DXA, foram determinados CMO, DMO e massa magra em três momentos: 40 semanas de idade pós-concepcional corrigida, 3 e 6 meses de idade pós-natal corrigida. Os recém-nascidos pré-termo apresentavam ao nascimento uma idade gestacional igual ou inferior a 32 semanas e receberam leite da própria mãe ou leite humano de banco. RESULTADOS: Todos os recém-nascidos apresentaram um aumento nos valores de CMO, DMO e massa magra durante o estudo. Os recém-nascidos pré-termo apresentaram menor CMO, DMO e massa magra, com 40 semanas de idade pós-concepcional corrigida, em relação aos recém-nascidos a termo (p < 0,001, p < 0,001, e p = 0,047, respectivamente). Entretanto, houve uma aceleração no processo de mineralização nos pré-termos, suficiente para atingirem os valores normais do recém-nascidos a termo aos 6 meses de idade corrigida. CONCLUSÕES: Este estudo sugere que a densitometria óssea de dupla absorção de Raios-X constitui um bom método para a avaliação dos parâmetros de composição corporal no início e no seguimento destes recém-nascidos pré-termo. .

Study progress in biological functions of Periostin in bone mineralization / 国际生物医学工程杂志

Periostin is a matri-cellular protein which was originally identified in MC3T3-E 1 osteoblast-like cell line,expressing in multiple tissues like bones,teeth,skin and cardiac valves.Periostin is also found in a large variety of cancers and injured tissues,involving in cancer cell invasion and metastasis as well as wound repair.Recent studies have suggested the role of Periostin in osteoblast adhesion and differentiation,fibrillogenesis,mineralization and bone fracture healing,and its expression is regulated by mechanical stress,various transcription factors,hormones and growth factors.In this article,we will discuss the expression,localization and general characteristics of Periostin,and provide a review on the study of it in bone biology.

Mineralización ósea en niños y adolescentes con hipotiroidismo congénito / Bone mineralization in children and adolescents presenting with a congenital hypothyroidisM

Introducción: en el hipotiroidismo congénito la mineralización ósea puede afectarse por la enfermedad o por los efectos del tratamiento con hormonas tiroideas.Objetivo: determinar en pacientes con hipotiroidismo congénito la mineralización ósea. Métodos: se realizó estudio descriptivo transversal pareado, en niños cubanos con hipotiroidismo congénito (n=67) y un grupo control (n=67). Se analizó la mineralización ósea por densitometría, y se tuvo en cuenta la edad, el sexo, la maduración ósea y sexual, el diagnóstico hormonal y el tratamiento. Se aplicaron intervalos de confianza (95 por ciento), análisis de varianza y correlación con significación. Resultados: la densidad, el contenido mineral óseo y el z-score en niños cubanos con hipotiroidismo congénito, y el grupo control no fue diferente significativamente (p=0,466; 0,155; 0,416 respectivamente). Estimaciones de asociación de mineralización ósea por edad mostró diferencia significativa en la densidad mineral ósea y contenido mineral óseo (p=0,000) para ambos grupos, y el z-score solo para los enfermos. La mineralización ósea fue significativa en la dosis promedio con levotiroxina en la segunda y tercera fase ósea, y en el tiempo de tratamiento. En el hipotiroidismo congénito permanente hubo correlación con el diagnóstico hormonal y el tiempo de tratamiento (p=0,000). Conclusiones: la mineralización ósea es homogénea en ambos grupos. La densidad y el contenido mineral óseo en niños cubanos con hipotiroidismo congénito y el grupo control se asocian con la edad, y son independientes del sexo. El z-score en pacientes con hipotiroidismo congénito sufre variación con la edad, y es independiente al sexo en ambos grupos. La densidad y el contenido mineral óseo varían en niños con hipotiroidismo congénito(AU)

Introduction: in the case of the congenital hypothyroidism the bone mineralization may be affected by disease or by the effects of the thyroid hormones treatment. Objective: to determine the bone mineralization in patients presenting with congenital hypothyroidism. Methods: a cross-sectional, matched and descriptive study was conducted in Cuban children with congenital hypothyroidism (n= 67) and a control group (n= 67). The bone mineralization was analyzed by densitometry taking into account age, sex, bone and sexual maturation, hormonal diagnosis and treatment. The 95 percent CI were applied, variance analysis and correlation with significance. Results: density, bone mineral content and z-score in Cuban children with congenital hypothyroidism and the control group there was significantly different (p= 0,466; 0,155; 0,416), respectively. The estimations of bone mineralization association according to age showed a significant difference in bone mineralization density and the bone mineral content (p= 0,000) for both groups, and the z-score only for the sick persons. The bone mineralization was marked in mean dose with levothyroxine during the second and third bone phase and the treatment time. In the case of permanent congenital hypothyroidism there was a correlation with hormonal diagnosis and the treatment time (p= 0,000). Conclusions: the bone mineralization is homogeneous in both groups. Density and bone mineral content in Cuban children with congenital hypothyroidism and the control group are associated with age independently of sex in both groups. Density and bone mineral content are different in the children with congenital hypothyroidism(AU)

Os glicocorticoides e seus efeitos no crescimento e na mineralização óssea / Effects of glucocorticoids on growth and bone mineralization

OBJETIVO: Revisar os mecanismos de ações dos glicocorticoides e sua capacidade de induzir osteoporose e déficits de crescimento. FONTES DOS DADOS: A revisão bibliográfica de artigos científicos foi realizada na base de dados MEDLINE e utilizou as palavras-chave agrupadas nas sintaxes “glicocorticoides”, “mineralização óssea”, “crescimento” e “efeitos colaterais”, nos últimos 10 anos, e das referências destes nos reportamos para as publicações mais antigas, mas com os estudos fundamentais para a compreensão do assunto. SÍNTESE DOS DADOS: Destacam-se ações dos glicocorticoides sobre hormônios e citocinas responsáveis pelo crescimento longitudinal. Os efeitos finais dos glicocorticoides sobre o esqueleto são determinados por ações sistêmicas no metabolismo ósseo e por ações diretas desses esteroides nas células ósseas, levando a mudanças no número e função das mesmas e favorecendo a perda óssea. Discutem-se os mecanismos indutores da recuperação dos canais de crescimento e recuperação da massa óssea após a descontinuação dos glicocorticoides; os métodos diagnósticos do metabolismo e mineralização óssea; assim como medidas terapêuticas e preventivas das alterações óssea induzidas pelos glicocorticoides. CONCLUSÃO: A monitorização de cada paciente é essencial para identificação e potencial reversão dos danos associados ao uso crônico de glicocorticoides.

OBJECTIVE: To review the various mechanisms of glucocorticoid action and the ability of these agents to induce osteoporosis and growth deficits. SOURCES: A review of the scientific literature was conducted on the basis of a MEDLINE search using the keywords and descriptors “glucocorticoids,” “bone mineralization,” “growth,” and “side effects” and limited to articles published in the last decade. The references cited by these articles were used to identify relevant older publications, with an emphasis on landmark studies essential to an understanding of the topic. SUMMARY OF THE FINDINGS: Emphasis was placed on the actions of glucocorticoids on the hormones and cytokines that modulate linear growth. The end effects of glucocorticoids on the skeletal system are the result of systemic effects on bone metabolism and of direct actions on bone cells, which alter bone cell counts and predispose to bone loss. The mechanisms underlying catch-up growth and bone mass recovery after discontinuation of glucocorticoid treatment are discussed, followed by a review of diagnostic methods available for assessment of bone metabolism and mineralization and of measures for prevention and management of glucocorticoid-induced bone changes. CONCLUSION: Patient monitoring on a case-by-case basis plays an essential role in detection and, potentially, reversal of the damage associated with chronic glucocorticoid therapy.

Association between anthropometric hormonal measurements and bone mineral density in puberty and constitutional delay of growth and puberty / Asociación entre las mediciones hormonales antropométricas y la densidad mineral ósea en la pubertad y el retraso constitucional del crecimiento y la pubertad

The aim of this study is to evaluate the acquisition of bone mineral in healthy children throughout puberty and in children with constitutional delay of growth and puberty (CDGP), and to relate changes in bone mass to age, weight, height, sitting height, body mass index and sex hormones in healthy boys. A total of 90 boys: 15 boys with CDGP and 75 healthy boys in different pubertal stages were examined. The number of children assigned to each Tanner stages was 15. Although bone age, weight and Body Mass Index (BMI) were significantly higher in stages II, III, IV, V compared to stage I and CDGP, mean height and sitting height values were higher in stages III, IV, V compared to stage I and CDGP. Also, serum FSH, LH, oestradiol, total and free testosterone levels progressively increased, although serum sex hormone binding globulin (SHBG) levels decreased, in healthy children with progression of sexual development. Significant increase was observed for serum oestradiol levels at stage II and above (p < 0.001), for serum total and free testosterone levels at stage III and above (p < 0.001), for serum FSH and LH levels at stage IV and above (p < 0.01 and p < 0.001) respectively. Also, it was shown that bone mineral content (BMC) and bone mineral density (BMD) measurements were significantly higher for pubertal stage lll and above groups according to both the CDGP group and stage I group. When BMD and BMC measurements of children with CDGP (0.62 ± 0.05 gr/cm² and 23.4 ± 2.8 gr) were compared with bone age, age, BMI and height-matched controls, there was no significant difference between children with CDGP and controls, except for age. Bone mineral density and BMC measurements in children with CDGP were significantly lower than those of age-matched controls (for pubertal stage lll: p < 0.05, for pubertal stage IV: p < 0.01). The strongest correlation coefficients were found between BMD and height among auxological parameters (r = 0.63, p < 0.001) and serum oestradiol levels among hormones (r = 0.55, p < 0.001). The most important findings of this investigation was the determination of body composition and hormonal measurement changes during puberty in boys; oestradiol was the most potent determinant of BMD among pubertal boys. We suggested that there is a critical age period for accumulation of bone mass according to the results. Longitudinal studies will elucidate why sufficient mineralization does take place after puberty starts in CDGP.

El objetivo de este estudio es evaluar la adquisición de mineral óseo del hueso en niños saludables a través de la pubertad y en niños varones con retraso constitucional del crecimiento y la pubertad (RCCP), y relacionar los cambios de masa ósea a la edad, el peso, la altura, la altura sentado, el índice de masa corporal, y las hormonas del sexo en niños varones saludables. Examinamos un total de 90 niños, 15 niños con RCCP y 75 niños saludables en diferentes etapas de la pubertad. El número de niños asignados a cada etapa de Tanner fue 15. Aunque la edad ósea, el peso y el IMC fueron significativamente más altos en las etapas II, III, IV, V, comparados con la etapa I y el RCCP; la altura promedio y los valores de la altura sentado fueron más altos en las etapas III, IV, V, comparados con la etapa I y el RCCP. Por otra parte, los niveles séricos de HEF, HL, estradiol y testosterona total y libre, aumentaron progresivamente, aunque los niveles séricos de SHBG disminuyeron en los niños saludables con el avance del desarrollo sexual. Se observó un aumento significativo en los niveles de estradiol sérico en la etapa II y por encima (p <0.001), en los niveles séricos de testosterona libre y total en la etapa II y por encima (p < 0.001), y en los niveles séricos de HEF, HL en la etapa IV y por encima (p < 0.01 y p < 0.001). Además se observó que las mediciones del contenido mineral óseo (CMO) y la densidad mineral ósea (DMO) fueron significativamente mayores en la etapa III de la pubertad y grupos por encima, de acuerdo tanto con el grupo de RCCP cómo el grupo de la etapa I. Cuando las mediciones de DMO y CMO de niños con RCCP (0.62 ± 0.05 gr/cm² y 23.4 ± 2.8 gr) fueron comparadas con la edad ósea, la edad, IMC y los controles pareados por altura, no se halló ninguna diferencia significativa entre los niños con RCCP y los controles, excepto la edad. Las mediciones de DMO y CMO en niños con RCCP fueron significativamente más bajas que las de los controles pareados por edad (para la etapa III de la pubertad: p < 0.05; para la etapa IV de la pubertad: p < 0.01). Los coeficientes de correlación más fuertes se encontraron entre la DMO y la altura entre los parámetros auxológicos (r = 0.63, p < 0.001), los niveles séricos de estradiol entre las hormonas (r = 0.55, p < 0.001). Los hallazgos más importantes de esta investigación fueron la determinación de la composición corporal y los cambios en la medición hormonal durante la pubertad en los muchachos; el estradiol fue el determinante más potente de la DMO entre los niños en la pubertad. Sugerimos que hay un periodo de edad crítico para la acumulación de masa ósea de acuerdo con nuestros resultados. Los estudios longitudinales esclarecerán por qué se produce suficiente mineralización después de que la pubertad empieza en RCCP.

Inclusão de ácidos graxos de cadeia curta em diferentes níveis de cálcio na dieta de frangos de corte / Inclusion of short chain fatty acids and different calcium levels in diets for broilers

Noventa e seis frangos de corte, machos, de linhagem Cobb e de 21 aos 31 dias de idade foram alimentados com a inclusão de ácidos graxos de cadeia curta (AGCC) e diferentes níveis de cálcio. Foram determinados o balanço de cálcio (Ca) e de fósforo (P), a metabolizabilidade da matéria seca (MetMS), matéria orgânica (MetMO) e matéria mineral, da energia bruta e proteína bruta da dieta, a porcentagem de cinzas nas tíbias ( por centoCzT), além do desempenho das aves. Utilizou-se um esquema fatorial 5x4 (sem ácido orgânico; ácido fórmico, ácido acético, ácido propiônico e ácido butírico) x (0,40, 0,59, 0,78 e 0,97 por cento de Ca), com um delineamento completamente casualizado. O acréscimo de Ca na dieta afetou de forma positiva e quadrática o balanço de Ca e P, sendo os melhores níves estimados em 0,87 e 0,75 por cento de Ca dietético, respectivamente, e afetou positiva e linearmente a MetMS e a MetMO, bem como a por centoCzT. Houve redução na eficiência de retenção do Ca, de forma quadrática, com o aumento do nível de cálcio. Os AGCC não apresentam efeitos detectáveis sobre as respostas estudadas e nem interação com os níveis dietéticos de Ca utilizados. A melhor exigência estimada de Ca dietético, considerando o balanço de cálcio, foi de 0,87 por cento.

Ninety six Cobb male broilers from 21 to 31 days of age were fed including short chain fatty acids (SCFA) and different level of calcium. Calcium (Ca), phosphorus (P), balance, dry, organic and mineral matter metabolizability, crude energy and crude protein metabolizability, tibia ash percentage and animal performance were measured. Experimental diets were assigned in a 5x4 factorial arrangement (without acids, formic acid, acetic acid, propionic acid and butyric acid) x (0.40, 0.59, 0.78 and 0.97 percent of Ca) in a randomized completely design. Increasing Ca levels affected positively and in a quadratic form Ca and P balance and the best levels were estimated at 0,87 percent and 0,75 percent of Ca dietary, respectively and affected linearly dry, organic matter metabolizability and tibia ash percentage. However, the efficiency of Ca retention was decreased quadratically with the increase of Ca level. The SCFA did not show detectable effects on the studied responses, and no interaction with dietary levels of Ca used. The estimated Ca requirement considering calcium balance was 0.87 percent.

Comparação entre duas dietas à base de leite humano em relação ao crescimento e à mineralização óssea de recém-nascidos de muito baixo peso / Comparison of two diets with modified human milk regarding growth and bone mineralization of very low birth weight infants

OBJETIVO: Comparar a eficácia e tolerabilidade de duas dietas à base de leite humano (LH) acrescido de fórmula láctea (PreNan®) ou complemento nutricional especial (FM 85®) na promoção do crescimento pôndero-estatural, mineralização óssea e tempo de hospitalização de recém-nascidos de muito baixo peso (RNMBP). MÉTODO: Foram constituídos, por sorteio, dois grupos de crianças acompanhadas a partir do 15º dia de vida, até atingir o peso de alta (2000±20g): Grupo A, 14 RNMBP receberam LH+FM 85® (5g/100mL LH); Grupo B, 11 RNMBP receberam LH+PreNan® 19 por cento em volumes iguais. Foram avaliados: peso, comprimento, perímetro cefálico e prega cutânea tricipital média esquerda, calculando-se os incrementos de peso e o tempo para atingir 2000g. Foram dosados: cálcio, fósforo, magnésio e creatinina séricos e urinários e fosfatase alcalina sérica, calculando-se as taxas de reabsorção tubular de fósforo ( por centoTPR). A mineralização óssea foi avaliada por meio de técnicas radiológicas padronizadas. RESULTADOS: 11 RNMBP de cada grupo completaram o estudo. Ambas as dietas foram bem toleradas e os índices antropométricos e dosagens séricas iniciais não apresentaram diferenças entre os grupos. Os incrementos de peso do Grupo B foram superiores aos do Grupo A e a fosfatase alcalina sérica do Grupo A foi maior que do Grupo B no final da observação. Não houve diferenças entre os grupos quanto à por centoTPR; mineralização óssea e tempo de hospitalização. CONCLUSÕES: Ambas as dietas foram bem toleradas. O leite humano enriquecido com PreNan® 19 por cento volume a volume (v/v) se mostrou mais eficiente em relação ao ganho de peso e ao metabolismo ósseo em comparação ao leite humano acrescido de FM 85®.

OBJECTIVE: To compare the efficacy and tolerability of two diets based on human milk (HM) added with PreNan® or FM 85® on physical growth, bone mineralization and duration of hospitalization. METHODS: Two groups of very low birth weight (VLBW) infants were studied: Group A, 14 infants fed with HM+FM 85® (5g/100mL HM) and Group B, 11 infants fed with HM+PreNan® 19 percent volume to volume (v/v), from the 15th day of life up to 2000g of weight. The parameters measured were: weight, length, head circumference; mean left triciptal skinfold thickness; calcium, phosphorus, magnesium and creatinine (serum and urine) and alkaline phosphatase (serum) at the beginning and at the end of the observation. The tubular phosphorus reabsorption rate ( percentTPR) was calculated and bone mineralization was assessed by X-ray. RESULTS: 11 infants of each group completed the study. There were no differences between the two groups at the beginning of the study. Weight gain per day (g/d) or per kg per day (g/kg/d) was significantly higher in Group B, and duration of hospitalization was shorter. Serum calcium, phosphorus and magnesium levels did not differ between groups, but alkaline phosphatase levels were higher in Group A at the end of the study. Groups were similar regarding bone mineralization and percentTPR. CONCLUSIONS: Both diets were well tolerated. In terms of weight gain and bone metabolism, supplementation of HM with PreNan® 19 percent v/v was slightly but significantly better than with FM 85®.

El eje hueso-riñón en el control del fósforo sérico y la mineralización ósea / Bone-Kidney axis in the control of serum phosphorus and bone mineralization

El eje hueso-riñón ha sido pensado como un mecanismo por el cual el esqueleto se comunica con el riñón para coordinar la mineralización de la matriz extracelular ósea con el manejo renal del fosfato. Osteoblastos /osteocitos están bien preparados para coordinar las homeostasis sistémica de fósforo y la mineralización ósea, ya que ellos expresan todos los componentes implicados en un posible eje hueso-riñón, incluyendo al PHEX, FGF-23, MEPE, y DMP1. Los efectos autocrinos de proteínas de la familia SIBLING como MEPE y DMP1 sobre los osteoblastos podrían regular la producción de proteínas de matriz extracelular que intervienen en la mineralización. El riñón provee uno de los efectores de este eje que regula el balance de fosfato a través de la expresión apical de los cotransportadores sodio/fosfato NaPi-IIa y NaPi-IIc en el túbulo proximal. Central en este eje es el FGF-23, producido por los osteoblastos que tiene acciones fosfatúricas sobre el riñón. Cuando se descubrió que el FGF23, la primera fosfatonina era de origen osteoblástico/osteocitico, quedó establecido el eje hueso-riñón. Probar definitivamente la existencia de este eje hueso-riñón y definir exactamente su rol fisiológico requerirá de investigaciones adicionales

The bone-kidney axis has been thought as a mechanism for the skeleton to communicate with the kidney to coordinate the mineralization of extracelular matrix with the renal handling of phosphate. Osteoblasts / osteocytes are well suited for coordinating systemic phosphate homeostasis and mineralization, since they express all of the implicated components of a possible bone-kidney axis, including PHEX, FGF-23, MEPE, and DMP1. In addition, autocrine effects of SIBLING proteins as MEPE and DMP1 on osteoblasts could regulate the production of ECM proteins that regulate mineralization. The kidney provides one of the effectors of the axis that regulates phosphate balance through the apical expression of NaPi-IIa and NaPi-IIc in proximal tubules. Central in this axis is FGF-23, produced by osteoblasts that has phosphaturic actions on the kidney. When FGF23, the first phosphatonin, was discovered to be of osteoblastic/osteocyte origin, the bone kidney axis was established. Proving the existence of this bone-kidney axis and defining its physiological role will require additional investigations